Search
Tuesday 26 May 2015
  • :
  • :
Latest Update

Volume Active Stocks in Focus: Chesapeake Energy Corporation, (NYSE:CHK), Mondelez International, (NASDAQ:MDLZ), Horizon Pharma, (NASDAQ:HZNP), Monster Beverage Corporation, (NASDAQ:MNST)

On Friday, Shares of Chesapeake Energy Corporation (NYSE:CHK), gained 5.38% to $15.28.

Chesapeake Energy Corporation, stated financial and operational results for the 2015 first quarter. Highlights comprise:

  • Average production of about 686,000 boe per day, an enhance of 14% year over year, adjusted for asset sales
  • Adjusted net income of $0.11 per fully diluted share and adjusted ebitda of $928 million
  • 2015 total production guidance raised to 640 – 650 mboe per day
  • 2015 capital guidance of about $3.5 – $4.0 billion reiterated
  • Additional 600 – 700 new Eagle Ford locations added following successful down spacing test results.

Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas and natural gas liquids (NGL) from underground reservoirs in the United States. It holds interests in natural gas resource plays, counting the Haynesville/Bossier Shales in northwestern Louisiana and East Texas; the Marcellus Shale in the northern Appalachian Basin of West Virginia and Pennsylvania; and the Barnett Shale in the Fort Worth Basin of north-central Texas.

Shares of Mondelez International, Inc. (NASDAQ:MDLZ), inclined 1.18% to $39.44, during its last trading session, hitting its highest level.

On May 5, D.E Master Blenders 1753 B.V. (DEMB) and Mondelez International, declared that they have received conditional approval from the European Commission to combine their respective coffee businesses and create the world’s leading pure-play coffee company - JACOBS DOUWE EGBERTS (JDE). The European Commission’s approval follows JDE’s commitment to divest the Carte Noire brand throughout the European Economic Area, the Merrild brand in Denmark and the Baltics, and licensing of the Senseo brand to a third party in Austria.

The World’s Leading Pure-Play Coffee Company

JDE will be the world’s leading pure-play coffee company with:

  • Annual revenues of more than €5 billion
  • 1 or No. 2 position in over 18 countries across Europe, Latin America and Australia
  • An international workforce of about 12,000 associates
  • A portfolio comprising some of the most well-known coffee brands around the world:
  • Power brands counting: Jacobs, Tassimo, Moccona, Senseo and L’Or
  • Leading local brands counting: Douwe Egberts, Kenco, Pilao and Gevalia.

Mondelez International, Inc., through its auxiliaries, manufactures and markets snack food and beverage products worldwide. The company offers biscuits, counting cookies, crackers, and salted snacks; chocolates, and gums and candies; powdered beverages and coffee; and cheese and grocery products.

At the end of Friday’s trade, Shares of Horizon Pharma plc (NASDAQ:HZNP), lost -6.02% to $27.62.

Horizon Pharma, declared its first quarter 2015 financial results.

Strong Growth Continues in Early 2015

“Horizon’s strong first-quarter 2015 performance reflects the outstanding work of our commercial team as we continue to execute our strategy of accelerating growth through strong commercial performance and expanded access for patients and targeted acquisitions,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “In particular, we’re extremely happy with the first-quarter results of our primary care business unit, where we saw noteworthy outperformance with our launch of PENNSAID 2% in addition to strong performance of DUEXIS and VIMOVO. We expect the acquisition of Hyperion, which closed yesterday, to further diversify our product portfolio and enhance our business performance. To that end, recently we’re raising our full-year 2015 guidance. We now forecast net sales of $590 to $610 million and adjusted EBITDA of $235 to $250 million.”

Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.

Finally, Monster Beverage Corporation (NASDAQ:MNST), ended its last trade with -10.47% gain, and closed at $128.47.

Monster Beverage Corporation, stated financial results for the first quarter ended March 31, 2015.

Long-Term Planned Partnership with The Coca-Cola Company

In August 2014, Monster Beverage and The Coca-Cola Company reached definitive agreements for a long-term planned partnership to accelerate growth for both companies in the global energy drink category. The transaction, which is subject to customary closing conditions, is predictable to close in the second quarter of 2015. In early February 2015, in accordance with its existing agreements with certain affected third-party distributors, the Company sent notices of termination to the applicable third-party distributors in the U.S., providing for the termination of their respective distribution agreements, to be effective at various dates starting in March 2015.

As a result, the Company incurred termination obligations regarding such terminations in the amount of $206.0 million during the 2015 first quarter. Such termination costs have been expensed in full and are comprised of in operating expenses for the 2015 first quarter. In addition, the Company recognized revenue of $39.8 million related to the acceleration of deferred revenue associated with the terminated distributors during the 2015 first quarter.

Monster Beverage Corporation, through its auxiliaries, develops, markets, sells, and distributes alternative beverage category beverages in the United States and internationally. It operates in two segments, Direct Store Delivery and Warehouse.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *